CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

Myocardial bridging: contemporary understanding of pathophysiology with implications for diagnostic and therapeutic strategies When, where, and how to target vascular inflammation in the post-CANTOS era? Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis Short-Term Progression of Multiterritorial Subclinical Atherosclerosis Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes 2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures 2019 ACC/AHA/ASE Advanced Training Statement on Echocardiography (Revision of the 2003 ACC/AHA Clinical Competence Statement on Echocardiography): A Report of the ACC Competency Management Committee From Focal Lipid Storage to Systemic Inflammation

GuidelineVolume 73, Issue 24, June 2019

JOURNAL:J Am Coll Cardiol. Article Link

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

SM Grundy, NJ Stone, AL Bailey et al. Keywords: ACC/AHA Clinical Practice Guidelines; biomarkers; coronary artery calcium score; pharmacological; cardiovascular disease; cholesterol; LDL-cholesterol; diabetes mellitus; drug therapy; hydroxymethylglutaryl-CoA reductase inhibitors/statins; hypercholesterolemia; lipids; patient compliance; primary prevention; risk assessment; risk reduction discussion; risk treatment discussion; secondary prevention; ezetimibe; proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors

FULL TEXT PDF